IRESSA vs SPRYCEL

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 17, 2026·How we rate

Possible drug interaction. IRESSA and SPRYCEL are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	IRESSA	SPRYCEL
Rating	70/100	72/100
Pharmacy pays	—	~$839.19 /30
Type	RX	RX
Active ingredient	GEFITINIB	DASATINIB
Manufacturer	Astrazeneca	Bristol Myers Squibb
Dosage forms	Tablet	Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Non-Small-Cell Lung Carcinoma	Lymphoid Leukemia, Myeloid Leukemia

iressa sprycel

Rating

70/100

72/100

Pharmacy pays

—

~$839.19 /30

Type

Active ingredient

GEFITINIB

DASATINIB

Manufacturer

Astrazeneca

Bristol Myers Squibb

Dosage forms

Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Non-Small-Cell Lung Carcinoma

Lymphoid Leukemia, Myeloid Leukemia

Frequently asked questions

Which is better-rated, Iressa or Sprycel?

By our independent rating, Sprycel scores higher — 3.6 vs 3.5 out of 5 for Iressa. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Iressa and Sprycel?

Iressa contains Gefitinib, while Sprycel contains Dasatinib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.